2013
DOI: 10.1177/193229681300700103
|View full text |Cite
|
Sign up to set email alerts
|

First Clinical Evaluation of a New Percutaneous Optical Fiber Glucose Sensor for Continuous Glucose Monitoring in Diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(20 citation statements)
references
References 32 publications
0
19
0
1
Order By: Relevance
“…40,41 In the research on the development of glucose sensor, sensing technologies using SBPs such as a galactose/glucose-binding protein and concanavalin A are well established and have been evaluated for continuous glucose monitoring in preclinical studies and human clinical studies. [42][43][44] However, measurement technology for glycated proteins employing SBPs has only recently been reported.…”
Section: Property Of Fructosyl Amino Acid-binding Proteinmentioning
confidence: 99%
“…40,41 In the research on the development of glucose sensor, sensing technologies using SBPs such as a galactose/glucose-binding protein and concanavalin A are well established and have been evaluated for continuous glucose monitoring in preclinical studies and human clinical studies. [42][43][44] However, measurement technology for glycated proteins employing SBPs has only recently been reported.…”
Section: Property Of Fructosyl Amino Acid-binding Proteinmentioning
confidence: 99%
“…Telemonitoring solutions for chronic conditions management are being assessed currently through multiple clinical [3][10] and economic studies [6] [7]. Some of the preliminary results conclude that the use of these technologies is not related to an improvement in health indicators [20].…”
Section: Discussionmentioning
confidence: 99%
“…From the handmade logbook reporting to stem-cells research, a wide variety of medical technologies are applied to maintain patient health. The healthcare industry and academics are fostering improvements in monitoring technologies: recently, the accuracy and reliability of a fibercoupled optical continuous glucose sensor was tested for 14 consecutive days in a clinical trial, showing promising results [3]; closed-loop artificial pancreas [4] can significantly reduce glucose variability, regardless patient adherence to treatment. Nevertheless, the patient should not be taken out of the equation.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3] One limitation of fluorescencebased sensors is that the detected fluorescence signal is often weak, which results in low signal-to-noise ratio, 4 and significantly compromises the sensor performance. This problem can be overcome in fiber-optical fluorescence sensors by shaping the fiber tip to increase the numerical aperture (NA) of the fiber thereby collecting more of the fluorescence signal, as demonstrated by Gao et al 5 by linear and step-wise tapering of silica fibers.…”
Section: Introductionmentioning
confidence: 99%